These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12774774)

  • 21. Renal transplantation in patients with Fabry disease.
    Sessa A; Meroni M; Battini G; Maglio A; Nebuloni M; Tosoni A; Panichi V; Bertagnolio B
    Nephron; 2002 Jun; 91(2):348-51. PubMed ID: 12053080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro study of encapsulation therapy for Fabry disease using genetically engineered CHO cell line.
    Naganawa Y; Ohsugi K; Kase R; Date I; Sakuraba H; Sakuragawa N
    Cell Transplant; 2002; 11(4):325-9. PubMed ID: 12162373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabry's disease.
    Adam T; Alexandrescu L; Voinea F; Toringhibel M; Hâncu A
    Rom J Intern Med; 2006; 44(4):455-64. PubMed ID: 18386622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anderson-Fabry disease and the heart.
    O'Mahony C; Elliott P
    Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pediatric aspects of Fabry's disease].
    Roche O; Orssaud C; Germain D; Dufier JL
    Arch Pediatr; 2007 Jul; 14(7):909-14. PubMed ID: 17459672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
    Breunig F; Wanner C
    J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabry disease and the skin: data from FOS, the Fabry outcome survey.
    Orteu CH; Jansen T; Lidove O; Jaussaud R; Hughes DA; Pintos-Morell G; Ramaswami U; Parini R; Sunder-Plassman G; Beck M; Mehta AB;
    Br J Dermatol; 2007 Aug; 157(2):331-7. PubMed ID: 17573884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabry disease: renal biopsy-proven cases from China.
    Zhang SH; Liu ZH; Zeng CH; Li SJ; Chen HP; Su J; Li LS
    J Nephrol; 2007; 20(6):716-26. PubMed ID: 18046674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy].
    Mignani R; Feriozzi S; Carraro G; Martinelli F; Cianciaruso B
    G Ital Nefrol; 2009; 26(5):577-84. PubMed ID: 19802803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of renal pathology in Fabry disease.
    Sessa A; Meroni M; Battini G; Righetti M; Nebuloni M; Tosoni A; Vago GL;
    Acta Paediatr Suppl; 2003 Dec; 92(443):6-8; discussion 5. PubMed ID: 14989458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fabry nephropathy in a female with superposed IgA glomerulonephritis].
    Pisani A; Sessa A; Sabbatini M; Andreucci MV; Fusco C; Balletta M; Cianciaruso B
    G Ital Nefrol; 2005; 22(4):385-9. PubMed ID: 16267800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fabry kidney disease.
    Moran V; Obrador GT; Thadhani R
    Saudi J Kidney Dis Transpl; 2003; 14(3):367-77. PubMed ID: 17657109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
    Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P
    Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Description of a new mutation in a female patient with Fabry disease].
    Correia E; Vidinha J; Rodrigues B; Santos L; Moreira D; Garrido J; Clara Sá Miranda M; Cabral C; Santos O
    Rev Port Cardiol; 2011 Oct; 30(10):789-93. PubMed ID: 22118130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
    Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ
    Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
    Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
    J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiac manifestation of Fabry's disease: current knowledge].
    Palecek T; Lubanda JC; Magage S; Karetová D; Bultas J; Linhart A
    Vnitr Lek; 2004 Nov; 50(11):846-51. PubMed ID: 15648965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.
    Rodrigues LG; Ferraz MJ; Rodrigues D; Pais-Vieira M; Lima D; Brady RO; Sousa MM; Sá-Miranda MC
    Neurobiol Dis; 2009 Jan; 33(1):48-56. PubMed ID: 18848893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria.
    Kleinert J; Kotanko P; Spada M; Pagliardini S; Paschke E; Paul K; Voigtländer T; Wallner M; Kramar R; Stummvoll HK; Schwarz C; Horn S; Holzer H; Födinger M; Sunder-Plassmann G
    Transpl Int; 2009 Mar; 22(3):287-92. PubMed ID: 18954370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.